Fredun Pharma Expands into Pet Care, Wellness with 2 Deals

Fredun Pharmaceuticals is transforming into a brand-led healthcare platform, with H1 FY27 seeing expansion in pet healthcare, premium wellness, and global markets. Key initiatives include acquiring a 26% stake in Goodman Vetcare for ₹300 crore, expanding its veterinary retail presence. They also acquired Furlicks, an oral-strip pet-wellness brand, planning to increase SKUs from 6 to 22. WAGR, a tech-enabled pet-parenting platform, is being developed as India's largest pet-care ecosystem. The company aims to transition from OEM to a 100% branded portfolio by 2029, targeting a doubling of revenue and profitability in 3-4 years. Manufacturing capacity is also being expanded with a new utility block at Palghar. Fredun also allotted bonus equity shares and further shares post-warrant conversion.